ADXS
Advaxis, Inc.

276
Mkt Cap
$4.42M
Volume
937.00
52W High
$0.801
52W Low
$0.027
Price
$0.0401
ADXS Fundamentals
Prev Close
$0.1036
Open
$0.0401
50D MA
$0.0706
Beta
-16.15
Avg. Volume
1,839.79
Loading...
Loading...
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Ayala Pharmaceuticals Inc.?
What is the 52-week high for Ayala Pharmaceuticals Inc.?
What is the 52-week low for Ayala Pharmaceuticals Inc.?
What is Ayala Pharmaceuticals Inc. stock price today?
What was Ayala Pharmaceuticals Inc. stock price yesterday?
What is the 50-day moving average of Ayala Pharmaceuticals Inc.?

Latest ADXS News

View
No ADXS news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.